Ethical Considerations in the Use of Direct-To-Consumer Advertising and Pharmaceutical Promotions: The Impact on Pharmaceutical Sales and Physicians

2003 ◽  
Vol 48 (3) ◽  
pp. 279-290 ◽  
Author(s):  
R. Stephen Parker ◽  
Charles E. Pettijohn
Author(s):  
Beverly Moy ◽  
Reshma Jagsi ◽  
Richard B. Gaynor ◽  
Mark J. Ratain

Public scrutiny has increased over potential conflicts of interest among oncology researchers and providers. Given the increased prevalence and complexity of industry relationships, oncologists are increasingly faced with ethical challenges when navigating their financial relationships with industry. Oncologists are continually dealing with changing conflict of interest policies within academic centers and professional societies. With the recent passage of The Sunshine Act, oncologists are beginning to understand the repercussions of this new law. The consequences of the increasing use of direct-to-consumer advertising on patients with cancer are also unclear. Finally, industry's perspective on the evolution of these relationships is not clearly understood. This manuscript discusses issues related to industry's influence on oncology practice and research.


2007 ◽  
Vol 458 ◽  
pp. 202-219 ◽  
Author(s):  
Kevin J Bozic ◽  
Amanda R Smith ◽  
Sanaz Hariri ◽  
Sanjo Adeoye ◽  
John Gourville ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document